v3.26.1
Taxation - Schedule of Deferred Tax Assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:      
Temporary difference in accounts receivable recognition $ 5,894 $ 5,815  
Temporary difference in research and development costs 3,033 2,995  
Accrued expense 414 408  
Net operating loss carried forward 12,896 11,961  
Share-based compensation 546 538  
Allowance for credit losses 3,754 4,033  
Total deferred tax assets 26,537 25,750  
Valuation allowance (14,756) (13,803) $ (13,840)
Deferred tax assets, net of valuation allowance $ 11,781 $ 11,947